Watch Ticker

PTC Therapeutics, Inc.

Go to PTC Therapeutics, Inc. Website

$51.11

-1.14 (-2.18%)

Live

Previous Close

$52.25

Day Range

$50.695 - $52.45

Previous Day Range

$51.35 - $52.86

Market Cap

$4.1 billion USD

Day Vol.

1.1 million

Previous Day Vol.

1.0 million

Currency

USD

Primary Exchange

Nasdaq

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that in...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Novartis - Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance

Novartis reported strong Q2 2025 financial performance with 11% sales growth, double-digit core operating income increase, and raised full-year guidance. Key growth drivers included oncology and specialty medicine brands like Kisqali, Entresto, and Pluvicto.

Related tickers: NVS, PTCT.

Read Full Article

N/A - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (CAPR) after the company announced that the FDA will hold an advisory committee meeting for its Biologics License Application, causing the stock price to drop.

Related tickers: CAPR, IART, PTCT.

Read Full Article

Trending Tickers

Please sign in to view